Rapid rational drug targeting of Merkel cell polyomavirus (MCV)-positive Merkel cell carcinoma (MCC) using the survivin inhibitor YM155.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: UPMC Hillman Cancer Center, University of Pittsburgh
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2571138835
